Navigation Links
Essentialis Appoints Mahendra G. Shah, Ph.D., to Board of Directors
Date:1/5/2012

SAN DIEGO, Jan. 5, 2012 /PRNewswire/ -- Essentialis, Inc., today announced the appointment of Mahendra G. Shah, Ph.D., a partner with the life sciences-focused venture capital firm Vivo Ventures, to its Board of Directors.  A biopharma executive noted for his expertise in business development and economic strategies, Dr. Shah becomes the sixth member of the Board of Directors for Essentialis, a company focused on the development of a breakthrough medicine for the treatment of cardiovascular and metabolic disease.  Its lead compound, DCCR, is now in Phase IIb trials for patients with very high triglycerides. 

"Dr. Shah brings to Essentialis his tested knowledge in business development, clinical design and pharma-board leadership," said Stuart Collinson, Ph.D., Chairman of the Board, Essentialis.  "Essentialis expects to release its Phase IIb trial data for DCCR in the coming weeks.  As we prepare to begin a new chapter with an exciting new compound for further evaluation, board members with Dr. Shah's range of experience will advance our development objectives."

Essentialis added Dr. Richard Pasternak, a renowned cardiologist and former Merck & Co., Inc. executive, and Mr. Aaron Berg, Essentialis president, who was recently promoted to Chief Executive Officer, to its board of directors in December 2011.

About Mahendra G. Shah, Ph.D.

Mahendra G, Shah, Ph.D., has been a venture partner at Vivo Ventures, a life sciences-focused venture fund, since March 2010.  Prior to joining Vivo Ventures, he served as chief executive for several biopharma companies.  From September 2005 to December 2009, he was the founder, chairman and CEO of Nextwave Pharmaceuticals Pediatric, a specialty biomedical company.  From 1993 to 2003, he served as chairman and CEO of First Horizon Pharmaceuticals, a publicly traded specialty pharmaceutical company, where he raised more than $200 million in the p
'/>"/>

SOURCE Essentialis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Essentialis Promotes Aaron Berg to Chief Executive Officer
2. Essentialis Strengthens Patent Protection of Its Novel ATP-Sensitive Potassium Channel Opener Portfolio
3. Essentialis to Submit SPA for Hypertriglyceridemia
4. Essentialis Meets Primary Endpoint in Phase 2b Trial of DCCR for Treatment of Hypertriglyceridemia and is Granted Extensive Patent Coverage in the US
5. Essentialis Completes Patient Enrollment in Phase 2 Trial of DDCR for Treatment of Dyslipidemia
6. PrimeraDx Appoints David Jackson as VP of Business Development
7. China Health Resource Appoints USA Acquisition Counsel
8. Winner Medical Appoints BDO China as Independent Auditor
9. Marken Appoints New Head of Global Quality Assurance
10. Delcath Appoints Gregory Gores, M.D. to Medical Advisory Board
11. Qforma Appoints Ian McGuinness as Vice President, Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Valeant Pharmaceuticals International, Inc. (NYSE: ... company,s Bridgewater, New Jersey location ... Drug Administration (FDA) relating to an inspection in June ... Aesthetic injectable, which was divested to Galderma S.A. in ... Valeant,s contract manufacturers (rather than Valeant,s own internal manufacturing) ...
(Date:9/30/2014)... MOUNTAIN VIEW, Calif. , Sept. 30, 2014 /PRNewswire/ ... today, which integrates with HealthKit in iOS 8 and ... with their doctors. The app harnesses native iOS technologies ... patients to maintain a robust connection with their doctors ... wearable health devices and the data they collect is ...
(Date:9/30/2014)... Sept. 30, 2014  Based on its recent ... & Sullivan recognizes Ventana Medical Systems, Inc. (Ventana), ... 2014 North American Frost & Sullivan Award for ... along with a focus on innovation and improving ... in tissue-based cancer diagnostic solutions for patients worldwide. ...
Breaking Medicine Technology:Valeant Pharmaceuticals' Bridgewater Location Receives Warning Letter From FDA 2HealthLoop Integrates with Apple's HealthKit Enabling Patients to Share Health Data with Their Doctors Right from their iPhone 2Frost & Sullivan applauds the diversity of Ventana products and services for the cancer diagnostics market 2Frost & Sullivan applauds the diversity of Ventana products and services for the cancer diagnostics market 3Frost & Sullivan applauds the diversity of Ventana products and services for the cancer diagnostics market 4
... Neb., May 15 Creighton Medical Laboratories, based at ... announced today that it has become the first clinical ... testing method for cancer. The method, called SNP array ... to study cancer for several years. However, Creighton Medical ...
... Case Demonstrating RenalGuard To Be PresentedFRANKLIN, Mass., May ... PLCSF), a company focused on innovative cardiac and ... will demonstrate its RenalGuard System(TM) at EuroPCR, the ... Cardiovascular Interventions (EAPCI), May 19-22, 2009, in Barcelona, ...
Cached Medicine Technology:Creighton Medical Laboratories First to Offer New Cancer Test 2Creighton Medical Laboratories First to Offer New Cancer Test 3PLC Medical Systems to Demonstrate RenalGuard(R) at EuroPCR 2009 2PLC Medical Systems to Demonstrate RenalGuard(R) at EuroPCR 2009 3PLC Medical Systems to Demonstrate RenalGuard(R) at EuroPCR 2009 4
(Date:9/30/2014)... and cardiac muscles contain few stem cells, heart ... heart attack. Now Tel Aviv University researchers are ... tissue engineering. , Dr. Tal Dvir and his ... Biotechnology, Department of Materials Science and Engineering, and ... sophisticated micro- and nanotechnological tools ranging in ...
(Date:9/30/2014)... 2014 A new report launched today by ... Longitudinal Study on Ageing) conducted by academics from ... Dublin, Ireland, has highlighted the serious, complex and ... disability population. , The IDS-TILDA study is the ... the only one in the world with the ...
(Date:9/30/2014)... MyServer2Go.com made an announcement recently that ... this year for its quality VPS solution, reliable support ... MyServer2Go.com is a professional and targeted website which reviewed ... announcement will help webmasters find the best VPS hosting ... http://www.arvixe.com ) is one of the fastest-growing and most ...
(Date:9/30/2014)... Wellington, New Zealand (PRWEB) September 30, 2014 ... offers the potential to improve breast cancer risk ... risk, according to a study published in Breast ... article, “Digital mammographic density and breast cancer risk: ... methods,” demonstrates a strong connection between breast density ...
(Date:9/30/2014)... home surrounded by loved ones comes too late for ... change the process so that more patients may die ... the Frances Payne Bolton School of Nursing at Case ... million grant from the National Institute of Nursing Research ... Aggressiveness of End of Life Cancer Care," will contribute ...
Breaking Medicine News(10 mins):Health News:A heartbeat away? Hybrid 'patch' could replace transplants 2Health News:Longitudinal report shows challenging reality of ageing with an intellectual disability 2Health News:Longitudinal report shows challenging reality of ageing with an intellectual disability 3Health News:Longitudinal report shows challenging reality of ageing with an intellectual disability 4Health News:Arvixe Is Named Best VPS Hosting by MyServer2Go.com 2Health News:Mammographic Density Offers Potential to Improve Prediction of Breast Cancer Risk and Development of Personalized Screening 2Health News:Mammographic Density Offers Potential to Improve Prediction of Breast Cancer Risk and Development of Personalized Screening 3Health News:Mammographic Density Offers Potential to Improve Prediction of Breast Cancer Risk and Development of Personalized Screening 4Health News:CWRU researchers receives $2.06 million to study how patients make end-of-life decisions 2
... Attention Deficit Hyperactivity Disorder, or ADHD, is widely recognized by ... in place. But as many as six percent of all ... Demonstrating a lack of refined motor skills, children with DCD ... staying organized at school. They appear to be uncoordinated ...
... , SUNDAY, April 3 (HealthDay News) -- There,s a ... women, but it depends on their body weight, researchers report. ... smokers who were not obese, but this strong association was ... study. Researchers analyzed data from 76,628 women, aged 50 ...
... test believe it is the most accurate yet in ... asbestos. Study results of this aptamer proteomic technology were ... April 2-6. In a blinded test performed under ... Research Network Biomarker Discovery Lab, the proteomic assay could ...
... NYU Langone Medical Center have investigated a novel protein ... can accurately identify proteins secreted from cancerous tumors caused ... American Association for Cancer Research 102nd Annual Meeting 2011 ... performed under the sponsorship of the National Cancer Institute,s ...
... Amanda Gardner HealthDay Reporter , SUNDAY, April 3 ... a new valve in a damaged heart is as good ... risk of stroke, researchers reported Sunday. Transcatheter ... in the heart via an artery in the leg or ...
... Reporter , SATURDAY, April 2 (HealthDay News) -- Men taking ... the risk of a heart attack or stroke, a small, ... 5 percent increase in the thickness of the large artery ... to the brain, the researchers from Emory University found. ...
Cached Medicine News:Health News:Clumsy kids who don't 'grow out of it' 2Health News:Study Links Smoking, Breast Cancer in Older Women 2Health News:Protein test detects early-stage, asbestos-related pulmonary cancer 2Health News:New test detects early-stage, asbestos-related pulmonary cancer 2Health News:Minimally Invasive Heart-Valve Procedure Shows Promise: Study 2Health News:Minimally Invasive Heart-Valve Procedure Shows Promise: Study 3Health News:Study Hints at Link Between Antidepressants and Heart Trouble 2Health News:Study Hints at Link Between Antidepressants and Heart Trouble 3
... A lower cost alternative to Equalizers, the ... transfers between two different vessel configurations. With the ... can be quickly and easily adjusted for test ... Ergonomic Design for Unparalleled Comfort Pick ...
... The Equalizer With 384 Well Plate ... the revolutionary features of the original Equalizerexpandable and ... autoclavable components, and in-lab calibration capabilities. In addition, ... tips down to 4.5mm for loading and accessing ...
Packaging: Set includes: Eight-channel pipette (10.8 mm with 0.5-5.0 μl capacity) 25 PrismStrip 96 tips with rack 2 FlexPlates with a holder...
The Biopette E has a comfortable, ergonomic design. Fully motorized piston drive. Virtually eliminates pipetting forces. User-friendly operator interface. Simple, precise volume setting. Rechargelabl...
Medicine Products: